Effect of rapamycin on islet xenograft survival.
Department of Preclinical Research, Sandoz Pharmaceuticals Ltd, Basel, Switzerland.
X
X
Lu
H J
HJ
Schuurman
J F
JF
Borel
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D006224:Cricetinae; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery*; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008647:Mesocricetus; D051379:Mice; D008808:Mice, Inbred CBA; D011090:Polyenes / Q000494:pharmacology*; D012016:Reference Values; D020123:Sirolimus; D014183:Transplantation, Heterologous / Q000276:immunology*
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus